本頁面由Tiger Trade Technology Pte. Ltd.提供服務

傳奇生物

21.92
+0.64003.01%
成交量:253.67萬
成交額:5,538.17萬
市值:40.48億
市盈率:-16.83
高:22.13
開:21.45
低:21.29
收:21.28
52周最高:45.30
52周最低:21.19
股本:1.85億
流通股本:8,138.20萬
量比:1.19
換手率:3.12%
股息:- -
股息率:- -
每股收益(TTM):-1.3026
每股收益(LYR):-0.9681
淨資產收益率:-22.53%
總資產收益率:-6.92%
市淨率:4.00
市盈率(LYR):-22.64

資料載入中...

2023/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/04/21

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/19

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/05

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/05

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/03

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/17

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/11

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/30

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/16

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals